| Literature DB >> 29296671 |
Michael M Gilbert1, Matthew D DeMars2,3, Song Yang4, Jessica M Grandner4, Shoulei Wang1, Hengbin Wang1, Alison R H Narayan1,2, David H Sherman1,2,3,5, K N Houk4, John Montgomery1,3,5.
Abstract
The diversification of late stage synthetic intermediates provides significant advantages in efficiency in comparison to conventional linear approaches. Despite these advantages, accessing varying ring scaffolds and functional group patterns from a common intermediate poses considerable challenges using existing methods. The combination of regiodivergent nickel-catalyzed C-C couplings and site-selective biocatalytic C-H oxidations using the cytochrome P450 enzyme PikC addresses this problem by enabling a single late-stage linear intermediate to be converted toEntities:
Year: 2017 PMID: 29296671 PMCID: PMC5746868 DOI: 10.1021/acscentsci.7b00450
Source DB: PubMed Journal: ACS Cent Sci ISSN: 2374-7943 Impact factor: 14.553
Figure 1Conceptual framework for late-stage diversification. Regiodivergent scaffold assembly followed by site-selective C–H oxidation presents a versatile strategy for accessing diverse products from a single late-stage intermediate.
Figure 2Synergy of small molecule catalysis and biocatalysis in late-stage diversification. (A) Regiodivergent reductive macrocyclization enabling access to 11- and 12-membered macrolactones. (B) Modular strategy for enabling site-selective biocatalytic oxidation with the potential to alter site of oxidation based on linker design.
Scope of Biocatalytic Macrocycle Oxidationa
R groups are depicted by the letters a–e shown at bottom. Major product is depicted in the table. Unless otherwise noted, percent yield refers to conversion to monohydroxylated products in preparative experiments, and ratios of monohydroxylated products are given in parentheses. Products 5b and 12b were evaluated in analytical scale experiments with comparison to authentic standards. Analysis of the identity of minor products is provided in the Supporting Information.
Figure 3(A) Lowest energy conformers of a model of structure 4, with DFT barriers (kcal/mol) to C–H abstraction at C3 and C10. (B) Transition structure of C3 (purple) hydrogen abstraction. (C) Transition structure of C3 (yellow) hydrogen. (D) Transition structure of C10 (green) hydrogen abstraction. (E) Transition structure of C10 (blue) hydrogen abstraction.
Figure 4(A) Snapshot of MD trajectory of 4 with linker a overlaid with a snapshot of 4 with linker c. (B) Closeup of Figure A snapshot with average C–OFe distances shown. (C) Snapshot of 4 with linker a with average H–O distances shown. (D) Plot of hydrogen (of substrate C3) to oxygen (of iron–oxo) distances vs C–H–O angles throughout the MD trajectory, with transition state (TS) geometry shown in red. (E) Snapshot of 4 with linker c with average H–O distances shown. (F) Plot of hydrogen (of substrate C10) to oxygen (of iron–oxo) distances and C–H–O angles throughout the MD trajectory, with TS geometry shown in red.